Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein

Greinacher, Andreas; Selleng, Kathleen; Mayerle, Julia; u.a.; Immune Response in COVID-19 Vacination Study Group

dc.contributor.author	Gawaz, Meinrad Paul
dc.contributor.author	Müller, Karin Anne Lydia
dc.date.accessioned	2024-10-30T10:03:55Z
dc.date.available	2024-10-30T10:03:55Z
dc.date.issued	2021
dc.identifier.issn	0006-4971
dc.identifier.uri	http://hdl.handle.net/10900/158588
dc.language.iso	en	de_DE
dc.publisher	Washington, DC : American Society of Hematology	de_DE
dc.relation.uri	https://dx.doi.org/ 10.1182/blood.2021012938	de_DE
dc.subject.ddc	610	de_DE
dc.title	Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein	de_DE
dc.type	Article	de_DE
utue.publikation.seiten	1269-1277	de_DE
utue.personen.roh	Greinacher, Andreas
utue.personen.roh	Selleng, Kathleen
utue.personen.roh	Mayerle, Julia
utue.personen.roh	u.a.
utue.personen.roh	Immune Response in COVID-19 Vacination Study Group
dcterms.isPartOf.ZSTitelID	Blood	de_DE
dcterms.isPartOf.ZS-Issue	14	de_DE
dcterms.isPartOf.ZS-Volume	138	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE